VOGX Short Volume

Vogenx Inc. (VOGX) operates in the Healthcare sector, specifically the Biotechnology industry, listed on NASDAQ, employing roughly 4 people, carrying a beta of 0.00 to the broader market. Vogenx is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutics for the treatment of serious diseases associated with dysfunctions in human metabolism, including post-bariatric hypoglycemia (PBH) and gastroparesis. public since 2026-08-12.

Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.

Latest Date
2026-08-14
Short Volume
7.1K
Total Volume
20.8K
Short %
33.95%
30-Day Avg Short %
38.33%

Showing 3 days of FINRA short volume data for Vogenx Inc..

Learn how short volume is reported and how to read the data →

Frequently asked VOGX short volume questions

What is the daily VOGX short volume?
As of Aug 14, 2026, Vogenx Inc. (VOGX) short volume is 7.1K shares against 20.8K total reported volume, or 33.95% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
How is VOGX short volume reported?
FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
What does VOGX short volume tell options traders?
Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.